152 related articles for article (PubMed ID: 31921012)
1. Characterization of a Novel Diarrheagenic Strain of
Gong Z; Shi X; Bai F; He X; Zhang H; Li Y; Wan Y; Lin Y; Qiu Y; Chen Q; Hu Q; Cao H
Front Microbiol; 2019; 10():2810. PubMed ID: 31921012
[No Abstract] [Full Text] [Related]
2. Comparative Screening of Digestion Tract Toxic Genes in Proteus mirabilis.
Shi X; Lin Y; Qiu Y; Li Y; Jiang M; Chen Q; Jiang Y; Yuan J; Cao H; Hu Q; Huang S
PLoS One; 2016; 11(3):e0151873. PubMed ID: 27010388
[TBL] [Abstract][Full Text] [Related]
3. [Etiological and molecular characteristics of diarrhea caused Proteus mirabilis].
Shi X; Hu Q; Lin Y; Qiu Y; Li Y; Jiang M; Chen Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):724-8. PubMed ID: 25174481
[TBL] [Abstract][Full Text] [Related]
4. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
[TBL] [Abstract][Full Text] [Related]
5. Involvement of polyphosphate kinase in virulence and stress tolerance of uropathogenic Proteus mirabilis.
Peng L; Jiang Q; Pan JY; Deng C; Yu JY; Wu XM; Huang SH; Deng XY
Med Microbiol Immunol; 2016 Apr; 205(2):97-109. PubMed ID: 26233310
[TBL] [Abstract][Full Text] [Related]
6. Biological Characteristics and Genetic Analysis of a Highly Pathogenic
Hu R; Wang X; Muhamamd I; Wang Y; Dong W; Zhang H; Wang Y; Liu S; Gao Y; Kong L; Ma H
Front Vet Sci; 2020; 7():589. PubMed ID: 33134334
[TBL] [Abstract][Full Text] [Related]
7. Clonal relatedness of Proteus mirabilis strains causing urinary tract infections in companion animals and humans.
Marques C; Belas A; Aboim C; Trigueiro G; Cavaco-Silva P; Gama LT; Pomba C
Vet Microbiol; 2019 Jan; 228():77-82. PubMed ID: 30593384
[TBL] [Abstract][Full Text] [Related]
8. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.
Fusco A; Coretti L; Savio V; Buommino E; Lembo F; Donnarumma G
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212280
[TBL] [Abstract][Full Text] [Related]
9. The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection.
Pearson MM; Mobley HLT
J Med Microbiol; 2007 Oct; 56(Pt 10):1277-1283. PubMed ID: 17893161
[TBL] [Abstract][Full Text] [Related]
10. Molecular Analysis, Biochemical Characterization, Antimicrobial Activity, and Immunological Analysis of Proteus mirabilis Isolated from Broilers.
Yeh HY; Line JE; Hinton A
J Food Sci; 2018 Mar; 83(3):770-779. PubMed ID: 29437227
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C in the Presence of Sub-Inhibitory Concentration of Aminoglycosides and Fluoroquinolones Alters
Kwiecińska-Piróg J; Skowron K; Bogiel T; Białucha A; Przekwas J; Gospodarek-Komkowska E
Antibiotics (Basel); 2019 Aug; 8(3):. PubMed ID: 31405233
[TBL] [Abstract][Full Text] [Related]
12. Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice.
Zunino P; Sosa V; Allen AG; Preston A; Schlapp G; Maskell DJ
Microbiology (Reading); 2003 Nov; 149(Pt 11):3231-3237. PubMed ID: 14600235
[TBL] [Abstract][Full Text] [Related]
13. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.
Fraga M; Scavone P; Zunino P
Antonie Van Leeuwenhoek; 2005 Jul; 88(1):25-34. PubMed ID: 15928974
[TBL] [Abstract][Full Text] [Related]
14. The molybdate-binding protein ModA is required for
Huang Y; Chen J; Jiang Q; Huang N; Ding X; Peng L; Deng X
Front Microbiol; 2023; 14():1156273. PubMed ID: 37180242
[TBL] [Abstract][Full Text] [Related]
15. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
[No Abstract] [Full Text] [Related]
16. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
[TBL] [Abstract][Full Text] [Related]
17. Chemical characterization and serological properties of a unique O-polysaccharide of the Proteus mirabilis Sm 99 clinical strain - Identification of a new, O81, serotype.
Zabłotni A; Arbatsky NP; Drzewiecka D; Shashkov AS; Knirel YA
Int J Biol Macromol; 2018 Oct; 118(Pt A):1131-1135. PubMed ID: 30001599
[TBL] [Abstract][Full Text] [Related]
18. Nasal immunization with attenuated Salmonella Typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract.
Scavone P; Umpiérrez A; Maskell DJ; Zunino P
J Med Microbiol; 2011 Jul; 60(Pt 7):899-904. PubMed ID: 21415205
[TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
[TBL] [Abstract][Full Text] [Related]
20. Interactions of Escherichia coli and Proteus mirabilis with mouse mononuclear phagocytes.
Wells CL; Jechorek RP; Nelson RD
J Med Microbiol; 1990 Nov; 33(3):153-63. PubMed ID: 2250285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
